Corcept therapeutics inc (CORT)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Product revenue, net

306,486

251,247

159,201

81,321

50,286

26,551

10,357

3,307

-

-

-

Collaboration revenue

-

-

-

-

-

-

-

-

-

-

29

Operating expenses:
Cost of sales

5,504

5,215

3,554

2,058

1,361

882

143

91

-

-

-

Research and development

89,017

75,247

40,376

23,844

15,419

18,372

20,470

14,074

21,001

18,949

14,402

Selling, general and administrative

100,359

81,289

62,416

45,240

36,949

34,916

31,240

25,414

11,331

8,488

5,877

Total operating expenses

194,880

161,751

106,346

71,142

53,729

54,170

51,853

39,579

32,332

27,437

20,279

Income from operations

111,606

89,496

52,855

10,179

-3,443

-27,619

-41,496

-36,272

-32,332

-27,437

-20,250

Interest and other income

5,070

2,657

-49

-2,039

-2,965

3,764

4,515

1,776

25

25

17

Interest and other income

-

-

-

-

-

-

-

-

3

1,496

101

Income before income taxes

116,676

92,153

52,806

8,140

-6,408

-

-

-

-

-

-

Income tax expense

22,495

16,743

-76,316

0

0

-

-

-

-

-

-

Net income

94,181

75,410

129,122

8,140

-6,408

-31,383

-46,011

-38,048

-32,354

-25,966

-20,166

Other comprehensive income (loss):
Net unrealized gain on available-for-sale investments, net of tax impact of $(20) and $(52), respectively

327

5

-75

0

0

-

-

-

-

-

-

Foreign currency translation loss, net of tax

4

-

-

-

-

-

-

-

-

-

-

Total comprehensive income

94,512

75,415

129,047

8,140

-6,408

-

-

-

-

-

-

Basic net income per share (in dollars per share)

0.82

0.65

1.14

0.07

-0.06

-

-

-

-

-

-

Diluted net income per share (in dollars per share)

0.77

0.60

1.04

0.07

-0.06

-

-

-

-

-

-

Basic and diluted net income (loss) per common share

-

-

-

-

-

-0.31

-0.46

-0.41

-0.39

-0.38

-0.38

Weighted-average shares outstanding used in computing net income per share
Basic (in shares)

114,349

115,343

113,527

110,566

106,883

100,978

-

-

-

-

-

Diluted (in shares)

122,566

126,688

124,515

116,139

106,883

100,978

-

-

-

-

-

Weighted average shares outstanding used in computing basic and diluted net loss per share

-

-

-

-

-

-

99,819

93,015

83,309

68,336

52,443